Mechanisms in anti-inflammation and resolution: The role of lipoxins and aspirin-triggered lipoxins

Brazilian Journal of Medical and Biological Research

Volumn 34, Issue 5, 2001, Pages 555-566

  Fierro, I M ^a,c   Serhan, C N ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Department of Physiological Sciences   (Brazil)

Author keywords

Inflammation; Lipoxins; Resolution

Indexed keywords

ACETYLSALICYLIC ACID; AUTACOID; CYTOKINE; HYDROXYICOSATETRAENOIC ACID; LIPID; LIPOXIN; LIPOXIN A; LIPOXYGENASE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL; BIOSYNTHESIS; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; AUTACOIDS; CYTOKINES; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPIDS; LIPOXINS; LIPOXYGENASE;

EID: 0035348171     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2001000500002     Document Type: Article

References (60)

1. Cotran RS, Kumar V & Collins T (1999). Robbins Pathologic Basis of Disease. 6th edn. W.B. Saunders Co., Philadelphia.
2. Qiu FH, Wada K, Stahl GL & Serhan CN (2000). IMP and AMP deaminase in reperfusion injury down-regulates neutrophil recruitment. Proceedings of the National Academy of Sciences, USA, 97: 4267-4272.
3. Serhan CN (1999). Lipoxins and aspirin-triggered 15-epi-lipoxins. In: Gallin JI & Snyderman R (Editors), Inflammation Basic Principles and Clinical Correlates. Lippincott Williams & Wilkins, Philadelphia.
4. Claria J & Serhan CN (1995). Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proceedings of the National Academy of Sciences, USA, 92: 9475-9479.
5. Serhan CN, Haeggestrom JZ & Leslie CC (1996). Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB Journal, 10: 1147-1158.
6. Levy BD, Bertram S, Tai HH, Israel E, Fischer A, Drazen JM & Serhan CN (1993). Agonist-induced lipoxin A4 generation: detection by a novel lipoxin A4-ELISA. Lipids, 28: 1047-1053.
7. Serhan CN (1994). Lipoxin biosynthesis and its impact in inflammatory and vascular events. Biochimica et Biophysica Acta, 1212: 1-25.
8. Pettitt TR, Rowley AF, Barrow SE, Mallet AI & Secombes CJ (1991). Synthesis of lipoxins and other lipoxygenase products by macrophages from the rainbow trout, Oncorhynchus mykiss. Journal of Biological Chemistry, 266: 8720-8726.
9. 4 ELISA. Journal of Pharmacology and Experimental Therapeutics, 287: 779-790.
10. 4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry, 34: 14609-14615.
11. 4 12-hydroxydehydrogenase in inflammation. Journal of Biological Chemistry, 275: 25372-25380.
12. 4 analogs with increased biologic activity. FASEB Journal, 12: 487-494.
13. Clish CB, O'Brien JA, Gronert K, Stahl GL, Petasis NA & Serhan CN (1999). Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proceedings of the National Academy of Sciences, USA, 96: 8247-8252.
14. Dahlen S-E & Serhan CN (1991). Lipoxins: bioactive lipoxygenase interaction products. In: Wong A & Crooke ST (Editors), Lipoxygenases and their Products. Academic Press, San Diego.
15. 4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Clinical Science, 77: 195-203
16. 4 modulates transmigrat on of human neutrophils across intestinal epithelial monolayers. Journal of Clinical Investigation, 92: 75-82.
17. 4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. Journal of Immunology, 156: 2264-2272.
18. 4. FASEB Journal, 13: 903-911.
19. 4 receptor interaction. Biochemistry, 34: 16678-16686.
20. Grandordy BM, Lacroix H, Mavoungou K, Krilis S, Crea AEG, Spur BW & Lee TH (1990). Lipoxin A4 inhibits phosphoinositide hydrolysis in human neutrophils. Biochemical and Biophysical Research Communications, 167: 1022-1029.
21. 4 stable analogs are demonstrable in human whole blood: modulation of leukocyte adhesion molecules and inhibition of neutrophil-endothelial interactions. Blood, 94: 4132-4142.
22. 4 receptor. Journal of Biological Chemistry, 272: 6972-6978.
23. 4 block allergen-induced eosinophil trafficking. Journal of Immunology, 164: 2267-2271.
24. Ramstedt U, Serhan CN, Nicolaou KC, Webber SE, Wigzell H & Samuelsson B (1987). Lipoxin A-induced inhibition of human natural killer cell cytotoxicity: studies on stereospecificity of inhibition and mode of action. Journal of Immunology, 138: 266-270.
25. Stenke L, Reizenstein P & Lindgren JA (1994). Leukotrienes and lipoxins - new potential performers in the regulation of human myelopoiesis. Leukemia Research, 18: 727-732.
26. 4 receptor that is regulated by interleukin (IL)-13 and interferon γ and inhibits tumor necrosis factor α-induced IL-8 release. Journal of Experimental Medicine, 187: 1285-1294.
27. Gewirtz AT, McCormick B, Neish AS, Petasis NA, Gronert K, Sethan CN & Madara JL (1998). Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs. Journal of Clinical Investigation, 101: 1860-1869.
28. 4 inhibits IL-1ß-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. Journal of Immunology, 164: 2660-2666.
29. Leszczynski D & Ustinov J (1990). Protein kinase C-regulated production of prostacyclin by rat endothelium is increased in the presence of lipoxin A4. FEBS Letters, 263: 117-120.
30. Scalia R, Gefen J, Petasis NA, Serhan CN & Lefer AM (1997). Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin. Proceedings of the National Academy of Sciences, USA, 94: 9967-9972.
31. 4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors. Journal of Biological Chemistry, 275: 27566-27575.
32. 4 on airway responses of asthmatic subjects. American Review of Respiratory Diseases, 145: 1281-1284.
33. 4 inhibits cholinergic neurotransmission through nitric oxide generation in the rabbit trachea. European Journal of Pharmacology, 287: 233-238.
34. Serhan CN (1997). L poxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? Prostaglandins, 53: 107-137.
35. 4 receptor transgenc mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. Journal of Clinical Investigation, 104: 309-316.
36. 4 inhibit tumor necrosis factor α-induced neutrophil responses and trafficking: regulators of a cytokine-chemokine axis. Journal of Experimental Medicine, 189: 1923-1929.
37. 4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophila. Journal of Immunology, 164: 1029-1036.
38. Godson C, Mitchell S, Harvey KH, Petasis NA, Hogg N & Brady HR (2000). Cutting edge: Lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-denved macrophages. Journal of Immunology, 164: 1663-1667.
39. Stenke L, Edenius C, Samuelsson J & Lindgren JA (1991). Deficient lipoxin synthesis: a novel platelet dysfunction in myeloproliferative disorders with special reference to blast cr sis of chronic myelogenous leukemia. Blood, 78: 2989-2995.
40. 4 on signal transduction events in Friend erythroleukemia cells. Proceedings of the Society for Experimental Biology and Medicine, 201: 169-173.
41. Serhan CN, Hirsch U, Palmblad J & Samuelsson B (1987). Formation of lipoxin A by granulocytes from eosinophilic donors. FEBS Letters, 217: 242-246.
42. 4. Impact of aspirin therapy. Circulation, 86: 56-63.
43. Katoh T, Takahashi K, DeBoer DK, Serhan CN & Badr KF (1992). Renal hemodynamic actions of lipoxins in rats: a comparative physiological study. American Journal of Physiology, 263: F436-F442.
44. Munger KA, Montero A, Fukunaga M, Uda S, Yura T, Imai E, Kaneda Y, Valdivielso JM & Badr KF (1999). Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis. Proceedings of the National Academy of Sciences, USA, 96: 13375-13380.
45. 4. Journal of Pharmacology and Experimental Therapeutics, 278: 950-956.
46. 4 stable analogs are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. Journal of Experimental Medicine, 185: 1693-1704.
47. Chavis C, Chanez P, Vachier I, Bousquet J, Michel FB & Godard P (1995). 5-15-diHETE and lipoxins generated by neutrophils from endogenous arachidonic acid as asthma biomarkers. Biochemical and Biophysical Research Communications, 207: 273-279.
48. Edenius C, Kumlin M, Bjork T, Anggard A & Lindgren JA (1990). Lipoxin formation in human polyps and bronchial tissue. FEBS Letters, 272: 25-28.
49. Sanak M, Levy BD, Clish CB, Chang N, Gronert K, Mastalerz L, Serhan CN & Szczeklik A (2000). Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. European Respiratory Journal, 16: 1-6.
50. Claria J, Titos E, Jimenez W, Ros J, Gines P, Arroyo V, Rivera F & Rodes J (1998). Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites. Gastroenterology, 115: 147-156.
51. Thomas E, Leroux JL, Blotman F & Chavis C (1995). Conversion of endogenous arachidonic acid to 5,15-diHETE and lipoxins by polymorphonuclear cells from patients with rheumatoid arthritis. Inflammation Research, 44: 121-124.
52. 4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases. American Review of Respiratory Disease, 141: 1453-1458.
53. 4 with human neutrophils. Journal of Biological Chemistry, 267: 16168-16176.
54. 4 receptors by aspirin-triggered lipoxins and selected peptides evokes ligand-specific responses in inflammation. Journal of Experimental Medicine, 191: 1197-1207.
55. Simchowitz L, Fiore S & Serhan CN (1994). Carrier-mediated transport of lipoxin A4 in human neutrophils. American Journal of Physiology, 267: C1525-C1534.
56. 4 receptor. Journal of Experimental Medicine, 180: 253-260.
57. Wikstrosm Jonsson E, Rosenqvist U & Dahlen SE (1998). Agonist and antagonist activities of the leukotriene analogue BAY u9773 in guinea pig lung parenchyma. European Journal of Pharmacology, 357: 203-211.
58. 4: a new class of ligand for the Ah receptor. Biochemistry, 38: 7594-7600.
59. Levy BD, Petasis NA & Serhan CN (1997). Polyisoprenyl phosphates in intracellular signaling. Nature, 389: 985-989.
60. Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N & Gronert K (2000). Novel functional sets of lipid-derived mediators with anti-inflammatory actions generated from omega-3 fatty acids via cyclooxygenase-2-NSAIDs and transcellular processing. Journal of Experimental Medicine, 192: 1197-1204.